Evidence map›Paper›PMID 38496121›Full record

ArticleCureus2024

Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases.

Ji Hoon Kim, Suho Kim, Hee-Chul Nam, Chang Wook Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ho-Jong Chun and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ji Hoon KimGastroenterology and Hepatology, Uijeongbu St. Mary's Hospital, Uijeongbu, KOR.
Suho KimRadiology, Seoul St. Mary's Hospital, Seoul, KOR.
Hee-Chul NamGastroenterology and Hepatology, Uijeongbu St. Mary's Hospital, Uijeongbu, KOR.
Chang Wook KimThe Catholic University of Korea, Internal Medicine, Uijeongbu, KOR.
Jae-Sung YooGastroenterology and Hepatology, Seoul St. Mary's Hospital, Seoul, KOR.
Ji Won HanGastroenterology and Hepatology, Seoul St. Mary's Hospital, Seoul, KOR.
Jeong Won JangGastroenterology and Hepatology, Seoul St. Mary's Hospital, Seoul, KOR.
Jong Young ChoiGastroenterology and Hepatology, Seoul St. mary's Hospital, Seoul, KOR.
Seung Kew YoonGastroenterology and Hepatology, Seoul St. Mary's Hospital, Seoul, KOR.
Ho-Jong ChunRadiology, Seoul St. Mary's Hospital, Seoul, KOR.
Sung-Eun LeeHematology, Seoul St. Mary's Hospital, Seoul, KOR.
Jung-Suk OhRadiology, Seoul St. Mary's Hospital, Seoul, KOR.
Pil Soo SungGastroenterology and Hepatology, Seoul St. Mary's Hospital, Seoul, KOR.
The Catholic University of Korea Uijeongbu St. Mary's Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with hematological diseases experience complications related to portal hypertension, including life-threatening complications such as variceal bleeding.

methodsWe analyzed the prognosis of patients with hematological diseases and portal hypertension treated with transjugular intrahepatic portosystemic shunts (TIPS) or portal vein stents. We retrospectively assessed patients with hematological diseases and portal hypertension who had variceal bleeding. We evaluated the characteristics and prognosis of the enrolled patients. A total of 11 patients with hematological diseases who underwent TIPS, or portal vein stenting, were evaluated.

resultsThe median follow-up period was 420 days. Of the 11 patients, eight showed resolution of portal hypertension and its complications following TIPS, or stent insertion. One patient experienced rebleeding due to incomplete resolution of portal hypertension, and two other patients also experienced rebleeding because they underwent TIPS closure or revision due to repetitive hepatic encephalopathy.

conclusionPortosystemic shunt and stent installation are effective treatment options for portal hypertension due to hematological diseases.

Indexed as

hematological malignanciesmyeloproliferative neoplasm diseaseportal vein stentingtransjugular intrahepatic portosystemic shunt (tips)venous varix

Identifiers

PMID38496121
PMCPMC10942847
OpenAlexW4392784052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.